NYEE HomeThe New York Eye and Ear Infirmary
Patient InfoHealthcare ProfessionalsSpecialties & ServicesSupport NYEEAbout Us
  Current Research
Clinical Trials in Ophthalmology
Ophthalmology
Research

Otolaryngology
Research

Pathology
& Laboratory Medicine
Research

Plastic &
Reconstructive
Surgery
Research

Institutional
Review Board
(IRB)

 
printer-friendly version of this pagePrinter-Friendly Page large print version of this pageLarge Print Version 

A One Year, Investigator-Masked, Prospective, Randomized, Naturalistic, Observational Study of the Safety and Efficacy of Lumigan, Xalatan and Travatan in the Management of Elevated IOP in Patients with Open-Angle Glaucoma and Ocular Hypertension

Principal Investigator: Paul Sidoti, MD

Enrollment Status: Open

Objective:  To evaluate the safety and efficacy of the newer intraocular pressure–lowering therapies (Lumigan®, Xalatan®, and Travatan®) as prescribed to normal clinical practice. 

Eligibility:  Contact Principal Investigator/Coordinator

Contact Information:  

  • Principal Investigator: Paul Sidoti, MD at (212) 979-4590
  • Study Coordinator: Katy Tai, CR Manager (212) 979-4251

 

Home > Current Research > Clinical Trials in Ophthalmology > A One Year, Investigator-Masked, Prospective, Randomized, Naturalistic, Observational Study of the Safety and Efficacy of Lumigan, Xalatan and Travatan in the Management of Elevated IOP in Patients with Open-Angle Glaucoma and Ocular Hypertension